Neola Medical AB (NEOLA) — Cash Flow-to-Debt Ratio
Neola Medical AB (NEOLA) has a Cash Flow-to-Debt Ratio of -1.26x as of December 2025, meaning its operating cash flow of Skr-3.77 Million could theoretically repay -1% of its total liabilities (Skr3.00 Million) in one year. Check Neola Medical AB (NEOLA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neola Medical AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Neola Medical AB across 8 annual periods. Also explore total assets of Neola Medical AB for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Neola Medical AB (2018–2025)
Year-by-year debt coverage analysis for Neola Medical AB. For market capitalisation and broader financial context, see NEOLA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.99x | Skr-11.95 Million | Skr3.00 Million | ▼ -71.0% |
| 2024 | -2.33x | Skr-10.84 Million | Skr4.65 Million | ▼ -149.1% |
| 2023 | -0.94x | Skr-6.54 Million | Skr6.99 Million | ▲ +13.6% |
| 2022 | -1.08x | Skr-8.50 Million | Skr7.84 Million | ▲ +50.1% |
| 2021 | -2.17x | Skr-6.93 Million | Skr3.19 Million | ▲ +13.6% |
| 2020 | -2.51x | Skr-6.08 Million | Skr2.42 Million | ▼ -82.4% |
| 2019 | -1.38x | Skr-2.07 Million | Skr1.50 Million | ▲ +30.0% |
| 2018 | -1.97x | Skr-1.32 Million | Skr671.00K | — |